Opportunity Information: Apply for PAR 18 900
The Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02, Clinical Trial Not Allowed) is a National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) funding opportunity built specifically to surface bold, high-innovation ideas in musculoskeletal research that may not fit comfortably within traditional NIH grant pathways. The central theme is scientific risk paired with strong potential payoff: projects are encouraged to spring from unusual observations, imaginative or controversial hypotheses, and unconventional concepts that meaningfully depart from prevailing theories or standard practice. In practical terms, this FOA is trying to create space for investigators to propose work that could open entirely new lines of inquiry or shift existing paradigms, even if the supporting evidence is early, the approach is unconventional, or the idea challenges current assumptions.
Scientifically, the program is positioned as disease-focused translational research within the NIAMS mission, with this particular pre-application targeting musculoskeletal diseases (the broader RISK program also spans skin and rheumatic diseases, but this X02 is the musculoskeletal-focused entry point). NIAMS invites studies that improve understanding of mechanisms underlying relevant diseases or conditions, as well as projects that develop or test diagnostics, therapeutic agents, or preventive interventions. The scope is explicitly pre-clinical and translational: work can advance an intervention or tool up to, but not including, first-in-human studies. Both this X02 and the companion R61/R33 mechanism are not intended to support clinical trials, and applications proposing clinical trial activity would be considered out of scope.
Structurally, the X02 is a pre-application mechanism and functions as an initial screening step for a larger, subsequent application. While submission of an X02 is described as highly recommended rather than strictly required, it is framed as the preferred first step toward the companion R61/R33 FOA (RFA-AR-19-013). Investigators submit an X02 to introduce the high-risk, high-impact concept and its fit with the RISK program’s goals. NIAMS then identifies which pre-applications are both highly innovative and strongly aligned with program priorities; those investigators are notified of the opportunity to submit a full R61/R33 application under the companion announcement. Because the X02 is tied closely to the R61/R33 pathway, prospective applicants are expected to review both FOAs to understand the full process and expectations.
Eligibility is broad across U.S.-based organizations and government entities. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (when not an institution of higher education); for-profit organizations (other than small businesses); small businesses; and other eligible organizations. The FOA also explicitly highlights inclusion of a range of institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, the opportunity is limited to domestic applicants: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
From the administrative details provided, this opportunity is an NIH discretionary grant in the health category (CFDA 93.846), with Funding Opportunity Number PAR 18 900. The original closing date listed is July 3, 2019, and the posting creation date is August 10, 2018. An award ceiling and expected number of awards are not specified in the provided data, which is consistent with some pre-application or program-specific announcements where the emphasis is on program fit and subsequent invitation rather than a defined standalone budget competition.
Overall, the X02 RISK pre-application is best understood as a gateway for musculoskeletal projects that are scientifically daring but still anchored in a plausible translational path. The program is trying to identify ideas that could materially reshape how musculoskeletal diseases are understood, diagnosed, prevented, or treated, while keeping the work firmly on the non-clinical side of the pipeline and using the pre-application to route the strongest, most relevant concepts into the full R61/R33 application process.Apply for PAR 18 900
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
- This funding opportunity was created on 2018-08-10.
- Applicants must submit their applications by 2019-07-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)
Previous opportunity: REQUEST FOR INFORMATION- El Salvador Power Efficiency and Reliability Improvement
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 900
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 900) also looked into and applied for these:
| Funding Opportunity |
|---|
| Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 - No Clinical Trial Allowed) Apply for RFA CA 19 004 Funding Number: RFA CA 19 004 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 (Collab) Clinical Trial Not Allowed) Apply for PAR 18 905 Funding Number: PAR 18 905 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 Clinical Trial Not Allowed) Apply for PAR 18 904 Funding Number: PAR 18 904 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed) Apply for RFA MD 18 011 Funding Number: RFA MD 18 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,300,000 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Apply for PA 18 906 Funding Number: PA 18 906 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) Apply for RFA RM 18 031 Funding Number: RFA RM 18 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) Apply for RFA RM 18 032 Funding Number: RFA RM 18 032 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1 Clinical Trial Optional) Apply for RFA RM 18 034 Funding Number: RFA RM 18 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24 Clinical Trial Optional) Apply for RFA RM 18 035 Funding Number: RFA RM 18 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1 Clinical Trial Optional) Apply for RFA RM 18 033 Funding Number: RFA RM 18 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sustainable Peri-urban Water and Sanitation services Apply for BAA DRC WASH 2018 Funding Number: BAA DRC WASH 2018 Agency: Democratic Republic of the Congo USAID-Kinshasa Category: Health Funding Amount: Case Dependent |
| New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed) Apply for PA 18 908 Funding Number: PA 18 908 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed) Apply for PA 18 907 Funding Number: PA 18 907 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trials Not Allowed) Apply for PAR 18 909 Funding Number: PAR 18 909 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required) Apply for PAR 18 910 Funding Number: PAR 18 910 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| U.S. - India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed) Apply for PAR 18 912 Funding Number: PAR 18 912 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)- Clinical Trial Not Allowed Apply for PA 18 914 Funding Number: PA 18 914 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation of PCOR Evidence (R18) Apply for RFA HS 18 002 Funding Number: RFA HS 18 002 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional) Apply for RFA MH 19 510 Funding Number: RFA MH 19 510 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed) Apply for PAR 18 923 Funding Number: PAR 18 923 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 900", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
